Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bisoprolol vs Verapamil in non-obstructive hypertrophic cardiomyopathy
2021-006953-77Phase 2Active
- Sponsor
- Aarhus University Hospital
- Start
- Jan 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of bisoprolol and verapamil in hypertrophic cardiomyopathy (HCM) (2 arms), sponsored by Aarhus University Hospital. Primary endpoint: Maximal oxygen consumption (VO2 max) difference between treatments. Started Jan 2022; status: active.
02
Drugs
bisoprololverapamil
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on 2021-006953-77.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-006953-77.